These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 124241)

  • 21. [Streptozotocin].
    Rudas B
    Arzneimittelforschung; 1972 May; 22(5):830-61. PubMed ID: 4340253
    [No Abstract]   [Full Text] [Related]  

  • 22. Structure-activity relationships in drug-induced pancreatic islet cell toxicity.
    Fischer LJ; Wold JS; Rickert DE
    Toxicol Appl Pharmacol; 1973 Oct; 26(2):288-98. PubMed ID: 4356363
    [No Abstract]   [Full Text] [Related]  

  • 23. Alloxan toxicity to the pancreatic B-cell. A new hypothesis.
    Malaisse WJ
    Biochem Pharmacol; 1982 Nov; 31(22):3527-34. PubMed ID: 6758791
    [No Abstract]   [Full Text] [Related]  

  • 24. [Structural and enzymatic changes in the islets of the rat pancreas following alloxan and streptozotocin administration].
    Hettwer H; Dahlmann B; Marjanovic SD
    Cell Mol Biol Incl Cyto Enzymol; 1978; 23(4):355-67. PubMed ID: 162617
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective effects of retinyl palmitate on streptozotocin- and alloxan-induced beta cell toxicity and diabetes in the rat.
    Chertow BS; Webb MD; Leidy JW; Cordle MB
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):27-44. PubMed ID: 2521747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
    Lazarus SS; Shapiro SH
    Diabetes; 1973 Jul; 22(7):499-506. PubMed ID: 4146293
    [No Abstract]   [Full Text] [Related]  

  • 27. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.
    Eizirik DL; Pipeleers DG; Ling Z; Welsh N; Hellerström C; Andersson A
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9253-6. PubMed ID: 7937750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of streptozotocin-induced diabetes in rats by pretreatment with cortisone.
    Wellmann KF; Volk BW
    Diabetologia; 1977 Aug; 13(4):331-7. PubMed ID: 144079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purified islet cells in diabetes research.
    Pipeleers D
    Horm Res; 1986; 23(4):225-34. PubMed ID: 2870975
    [No Abstract]   [Full Text] [Related]  

  • 31. -to: B.M. Kim et al.: Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats. Diabetologia 44: 2192-2202.
    De Vos P
    Diabetologia; 2002 Jun; 45(6):931; author reply 932. PubMed ID: 12154775
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
    Weide LG; Lacy PE
    Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator.
    Fischer LJ; Hamburger SA
    Diabetes; 1980 Mar; 29(3):213-6. PubMed ID: 6991324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan.
    Tyrberg B; Andersson A; Borg LA
    Gen Comp Endocrinol; 2001 Jun; 122(3):238-51. PubMed ID: 11356036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitotic activity of islet cells in alloxan and streptozotocin diabetic mice studies by radioautography.
    Logothetopoulos J; Brosky G
    Diabetes; 1968; 17():306. PubMed ID: 4870770
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice.
    Papaccio G; Esposito V
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(1):5-10. PubMed ID: 1531718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological changes in the pancreatic islets of alloxan-treated mice, with comments on beta-cell regeneration.
    Patent GJ; Alfert M
    Acta Anat (Basel); 1967; 66(4):504-19. PubMed ID: 4864842
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.